Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum DRI Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence... see more

TSX:DHT.UN - Post Discussion

DRI Healthcare Trust > Clear legal Cause to Terminate DRI Capital / Persis
View:
Post by Hanalyst727 on Jul 08, 2024 8:35pm

Clear legal Cause to Terminate DRI Capital / Persis

To Directors and Shareholders:

 

Clearly we have an admission of Cause by the manager (DRI Captial). Item 2 of Cause (see below) is clearly met as DRI Capital embezzled / misappropriated funds against the Trust, and obviously caused the Trust material harm with the share price down 25% today.

 

If DRI Trust can either buy DRI Capital, or cancel its management contract and build in-house management, then this affair could be a positive in the long term. At this point it is likely even in Persis Holdings own interest to put a line under this and offload DRI Capital to the Trust and may even result in greater return in the long run.

The investment thesis is still in tact and all that matters is ability to close deals for the long term, get a grip on management, and stop issuing units. See: Constellation Software as model.

 

 

Excerpts from page 23 of the 2023 Annual Information Form,

 

During the initial term and each renewal term, the management agreement may only be terminated by us for Cause (as defined below). We will have the right to terminate our manager following:

 

(i) a determination of Cause by a court or governmental body of competent jurisdiction in a final judgement, or

(ii) an admission of Cause by our manager.

 

“Cause” will exist where:

(i) our manager defaults in the performance or observance of any material term, condition or covenant contained in the management agreement that results in a material harm to us and such default continues for a period of 60 days after written notice thereof by us to our manager specifying such default and requesting that the same be remedied in such 60-day period,

(ii) our manager engages in any act of fraud, misappropriation of funds or embezzlement against us and such act results in material harm to us,

(iii) our manager is grossly negligent in the performance of its duties under the management agreement and such gross negligence results in material harm to us,







Comment by SONOFFERGUS on Jul 09, 2024 10:26am
Leverage! IMHO a huge buying opportunity.  As I said elsewhere, trustees will need a huge concession from the manager to be seen to meet their fiduciary obligations.  Gary was in government and is on a lot of boards -- he knows what needs to happen.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities